|
Market Closed -
NSE India S.E.
19:05:10 28/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1,757.50 INR | +0.36% |
|
+0.83% | +2.20% |
| Market Cap | 4,217B 44.39B 39.84B 36.79B 33.36B 62.35B 63.12B 441B 175B 2,210B 167B 163B 7,009B | P/E 2027 * |
32.7x | P/E 2028 * | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3,925B 41.32B 37.09B 34.24B 31.05B 58.04B 58.75B 411B 163B 2,057B 155B 152B 6,524B | EV / Sales 2027 * |
6.03x | EV / Sales 2028 * | 5.3x |
| Free-Float |
44.39% | Yield 2027 * |
0.97% | Yield 2028 * | 1.14% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SUNPHARMA | Delayed | |
Bombay S.E.
| SUNPHARMA | Delayed |
Last Transcript: Sun Pharmaceutical Industries Ltd.
| 1 day | +0.36% | ||
| 1 week | +0.83% | ||
| Current month | -3.25% | ||
| 1 month | -5.11% | ||
| 3 months | -10.95% | ||
| 6 months | +1.38% | ||
| Current year | +2.20% |
| 1 week | 1,719.1 |  | 1,767.9 |
| 1 month | 1,719.1 | | 1,865 |
| Current year | 1,583.7 | | 2,046.9 |
| 1 year | 1,583.7 | | 2,046.9 |
| 3 years | 1,068.35 | | 2,046.9 |
| 5 years | 733.7 | | 2,046.9 |
| 10 years | 312 | | 2,046.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 59 | 01/09/2025 | |
| Director of Finance/CFO | 58 | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 59 | 01/09/2025 | |
| Director/Board Member | 71 | 21/05/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.36% | +0.83% | +3.77% | +58.15% | 44.24B | |
| +0.57% | +1.31% | +56.99% | +127.58% | 1,143B | |
| +0.81% | +4.90% | +44.66% | +83.92% | 647B | |
| +0.24% | +0.65% | +25.98% | +102.03% | 506B | |
| -0.05% | +1.73% | +52.74% | +65.27% | 384B | |
| -0.69% | -6.27% | +61.42% | +36.82% | 350B | |
| +0.34% | +1.84% | +30.70% | +52.69% | 293B | |
| -0.23% | +1.41% | +3.11% | +25.19% | 265B | |
| +0.45% | +2.66% | +54.06% | +70.98% | 242B | |
| +0.22% | +3.80% | +35.23% | +104.98% | 197B | |
| Average | +0.17% | +0.81% | +36.87% | +72.76% | 407.18B | |
| Weighted average by Cap. | +0.28% | +0.70% | +43.95% | +86.52% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 651B 6.85B 6.15B 5.68B 5.15B 9.63B 9.74B 68.1B 27.04B 341B 25.73B 25.18B 1,082B | 730B 7.68B 6.89B 6.37B 5.77B 10.79B 10.92B 76.31B 30.31B 382B 28.83B 28.22B 1,213B |
| Net income | 130B 1.36B 1.22B 1.13B 1.02B 1.92B 1.94B 13.55B 5.38B 67.89B 5.12B 5.01B 215B | 155B 1.63B 1.47B 1.35B 1.23B 2.29B 2.32B 16.23B 6.44B 81.31B 6.13B 6B 258B |
| Net Debt | -292B -3.07B -2.76B -2.55B -2.31B -4.32B -4.37B -30.54B -12.13B -153B -11.54B -11.29B -485B | -353B -3.71B -3.33B -3.08B -2.79B -5.21B -5.28B -36.89B -14.65B -185B -13.94B -13.64B -586B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | ₹1,757.50 | +0.36% | 1,056,767 |
| 27/10/26 | ₹1,751.20 | +0.64% | 1,547,898 |
| 26/10/26 | ₹1,740.00 | -0.46% | 1,622,698 |
| 23/10/26 | ₹1,748.00 | -0.57% | 1,064,528 |
| 22/10/26 | ₹1,758.00 | +0.74% | 1,778,519 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUNPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
